Dear European Chamber Member,

The European Chamber is delighted to welcome you to our upcoming Healthcare Seminar and Mixer at 16:00 on 27th June 2012 at European Chamber Shanghai Office. The seminar will bring an overview on Healthcare investment trends in China and challenges and obstacles for healthcare reform. Detailed Agenda and Introduction of speakers are attached below for your review.

 
Agenda

16:00 – 16:30 Healthcare Investments in China – current trends in the Med Device, Pharma and related spaces. By Mr. Matthew Guagenty, Managing Principal, China, Consulting and Services, IMS Consulting Group

Recent trends of investments in the Pharma and Med Device space.   We’ll briefly look at the organic and inorganic investments being made within the industry.   The discussion will look at operational, portfolio, product and R&D based investments.   Specific examples of investments will be briefly touched upon to illustrate the different pursuits being taken by the various players in the industry.  Ultimately the discussion will focus on a few common themes and the medium term implications on the evolution of the China market.

16:30 – 17:00 China Healthcare Reform - challenges and opportunities for MNC pharma and device companies. By Mr. Clement Ngai, Partner of Baker & McKenzie Shanghai Office

Almost 3 years since the Chinese government announced the ambitious healthcare reform plan in 2009, there have been many changes in the pharmaceutical and healthcare sector. The last few years have not been particularly for domestic pharmaceutical companies. Still the industry as whole manages a year-over-year growth of around 30% in 2011. In addition, the pharmaceutical industry is one of the 7 key industries in China's 12th Five-Year Plan. The Five-Year Plan has lofty growth targets as well as high expectation on drug quality standards. At the same time, drug pricing has been under enormous pressure due to cost containment measures from the government. What do all these means for pharma companies in China?

17:00 – 17:20 Q&A
17:20 - Networking

 
Introduction of the Speakers

Mr. Guagenty has served as an advisor to top global pharma, biotech and medical device clients across a range of commercial and functional areas.  With over five years in the pharma industry and another eleven in healthcare consulting, Matthew brings a mix of practical functional, industry and geographic expertise.  Matthew’s focus in the last seven years of management consulting has been advising clients related to growth strategies and new commercial approaches for both newly launching and established brands.  Most recently he has been evolving the thinking around launch success in China as well as supporting the development of innovative approaches to product valuation via best-in-class assets and methodologies.  Biography attached for your review.

Mr. Ngai’s practice focuses on pharmaceutical/regulatory and technology transactions in China.  He is technically trained and obtained a Masters in Biochemistry before becoming a lawyer. Prior joining the Firm, Mr. Ngai was the Chief IP Counsel in Asia for a multinational corporation with a significant presence in China and was responsible for all IP matters in the region (except India).  In this capacity he was extensively involved in technology development and IP issues relating to R&D Centers in China, particularly in the areas of chemicals and materials science.  In addition, Clement also served as the Chairman of the Business Software Alliance (BSA) China Committee from 2000-2006 when he was Asia Pacific counsel for a US software company.  In this role, he represented the interests of the US software industry in lobbying the Chinese government for the better protection of software IP rights.  He was also in charge of BSA’s anti-piracy program in China.

Event Terms & Conditions

Please note that, though all are welcome to attend our events, we strongly recommend that you register online with us in advance so that we can keep you updated on any changes in the event schedule. From time to time, due to unforeseen circumstances we need to change the time or venue of an advertised event. So please do let us know by registering online if you plan to attend an event so that we can keep you informed.

To register for this event please register online by 18:00pm 14th June. Please note that we will send you a registration confirmation. We require 24 hours notice for cancellations, no-shows who fail to cancel before this time will be invoiced for the event. Registrations done after the deadline will be accepted only if space permits and are charged an additional 50 RMB walk-in fee. For any further enquiries or registration, please contact us at xchen@europeanchamber.com.cn

Downloads

Related

Contact